Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Asset Writedowns and Impairment (2018 - 2023)

Viemed Healthcare (VMD) has disclosed Asset Writedowns and Impairment for 4 consecutive years, with $4.1 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Asset Writedowns and Impairment rose 19.91% year-over-year to $4.1 million, compared with a TTM value of $10.7 million through Mar 2023, up 25.54%, and an annual FY2022 reading of $10.0 million, up 45.19% over the prior year.
  • Asset Writedowns and Impairment was $4.1 million for Q1 2023 at Viemed Healthcare, up from $2.2 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $4.1 million in Q1 2023 and bottomed at $1.5 million in Q3 2020.
  • Average Asset Writedowns and Impairment over 4 years is $2.3 million, with a median of $2.1 million recorded in 2020.
  • The sharpest move saw Asset Writedowns and Impairment tumbled 42.06% in 2021, then surged 89.39% in 2022.
  • Year by year, Asset Writedowns and Impairment stood at $2.1 million in 2020, then decreased by 21.1% to $1.6 million in 2021, then soared by 33.74% to $2.2 million in 2022, then surged by 87.77% to $4.1 million in 2023.
  • Business Quant data shows Asset Writedowns and Impairment for VMD at $4.1 million in Q1 2023, $2.2 million in Q4 2022, and $1.5 million in Q3 2022.